APA (7th ed.) Citation

L, J., Y, L., H, M., Y, X., M, Y., W, W., . . . SG, T. (2019). Safety and efficacy of ertugliflozin in Asian patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: VERTIS Asia. Diabetes, obesity & metabolism, 21(6), 1474. https://doi.org/10.1111/dom.13681

Chicago Style (17th ed.) Citation

L, Ji, et al. "Safety and Efficacy of Ertugliflozin in Asian Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin Monotherapy: VERTIS Asia." Diabetes, Obesity & Metabolism 21, no. 6 (2019): 1474. https://doi.org/10.1111/dom.13681.

MLA (9th ed.) Citation

L, Ji, et al. "Safety and Efficacy of Ertugliflozin in Asian Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin Monotherapy: VERTIS Asia." Diabetes, Obesity & Metabolism, vol. 21, no. 6, 2019, p. 1474, https://doi.org/10.1111/dom.13681.